<?xml version="1.0" encoding="UTF-8"?>
<p id="par0120">For patients in general, the clinical characteristics resulting from contact with MERS-CoV, SARS-CoV, and SARS-CoV-2 can trigger an asymptomatic condition, mild symptoms such as a cold with or without fever. However, symptoms can progress to severe cases, corresponding to 25 % of patients infected with SARS-CoV-2 [
 <xref rid="bib0115" ref-type="bibr">23</xref>], for acute respiratory distress, pneumonia, gastrointestinal problems, liver damage, septic shock, and multiple organ failure, which can lead to death [
 <xref rid="bib0260" ref-type="bibr">52</xref>,
 <xref rid="bib0390" ref-type="bibr">78</xref>,
 <xref rid="bib0395" ref-type="bibr">79</xref>]. Especially in severe cases, SARS-CoV-2 may present multifocal nodular and ground-glass opacities surrounding the pulmonary lobes [
 <xref rid="bib0400" ref-type="bibr">80</xref>] in which there is an increase in the parenchyma attenuation coefficient, with preservation of bronchovascular marks [
 <xref rid="bib0405" ref-type="bibr">81</xref>]. In addition, regarding infected pregnant women, some points should be considered, such as symptomatic changes, vertical transmission to the fetus, and classification in risk groups.
</p>
